Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, ...

Type 1 diabetics have a lower risk of experiencing a cardiovascular event such as a stroke or heart attack than type 2 diabetics, a new study has found. It highlights the fundamental difference ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

Discover how this diabetes drug is revolutionizing heart health. Learn about its surprising benefits in reducing cardiovascular risks and mortality.

Diabetes is a chronic disease that involves an elevated level of blood sugar. It has a high risk of causing heart disease due ...

More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to recover with a few proven lifestyle changes.

A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, ...

Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...

A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...

Aging is a natural process, but certain lifestyle choices can accelerate age-related diseases such as diabetes, heart disease ...

Blood pressure. Having both diabetes and high blood pressure dramatically increases heart disease risk. Triglycerides and low ...

Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.